As soon as the US has a good base number of employees plus sales from Europe we flip to profit-making pretty quickly, they will keep treading close to that line and invest in R&D. Grants will be some icing on the cake.
It's borderline now and with each sales member contributing 1 mil in sales at a 90% GP it could happen in months, not years.
DW and PB control when we go green, they choose when to flick the switch. Good management will see us stay right on the line between profit and reinvestment. If the opportunity comes up to scale up in a big way then i trust them, DW is a master at managing capital and ensuring we have enough at the right times
Ann: PNV brings Breast Device in-house, page-27
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add PNV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$2.47 |
Change
-0.120(4.63%) |
Mkt cap ! $1.704B | |||
| Open | High | Low | Value | Volume |
| $2.58 | $2.58 | $2.47 | $3.191M | 1.271M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 15844 | $2.47 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.48 | 22823 | 2 |
View Market Depth
| Last trade - 16.10pm 18/07/2024 (20 minute delay) ? |
| PNV (ASX) Chart |